Wide Ranks

MLTX

MoonLake Immunotherapeutics

54.24

Top Statistics
Market Cap 3 B Forward PE -21.35 Revenue Growth 0.00 %
Current Ratio 25.51 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -27.08 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 493 M Total Cash Per Share 7.83 Total Debt 3 M
Total Debt To Equity 0.6820 Current Ratio 25.51 Book Value Per Share 7.74
All Measures
Short Ratio 3606.00 % Message Board Id finmb_713684532 Shares Short Prior Month 8 M
Return On Equity -0.1680 City Zug Uuid e27878d5-f881-3e1b-8a06-8dc9330a65f3
Previous Close 52.84 First Trade Date Epoch Utc 1 B Book Value 7.74
Beta 1.28 Total Debt 3 M Volume 76068
Price To Book 7.01 Fifty Two Week Low 37.55 Total Cash Per Share 7.83
Shares Short Previous Month Date 1 B Target Median Price 72.00 Max Age 86400
Recommendation Mean 1.50 Sand P52 Week Change 0.3133 Target Mean Price 73.92
Net Income To Common -80768080 Short Percent Of Float 0.3077 Implied Shares Outstanding 63 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 218230
Average Volume10days 218230 Total Cash 493 M Next Fiscal Year End 1 B
Held Percent Insiders 0.1522 Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 52.84 Target Low Price 55.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 50.25 Open 53.09
Free Cashflow -67301544 Dividend Yield 0.00 % Return On Assets -0.1332
Time Zone Short Name EST Trailing Eps -1.27 Day Low 52.37
Address1 Dorfstrasse 29 Shares Outstanding 63 M Price Hint 2
Target High Price 104.00 Website https://www.moonlaketx.com 52 Week Change 0.2353
Average Volume 308670 Forward Eps -2.51 Recommendation Key strong_buy
Compensation As Of Epoch Date 1 B Quick Ratio 2471.60 % Is_sp_500 False
Regular Market Day High 54.60 Profit Margins 0.00 % Debt To Equity 0.6820
Fifty Two Week High 64.98 Day High 54.60 Shares Short 8 M
Regular Market Open 53.09 Industry Key biotechnology Earnings Growth 0.00 %
Revenue Growth 0.00 % Shares Percent Shares Out 0.1269 Operating Cashflow -80457912
Currency USD Time Zone Full Name America/New_York Market Cap 3 B
Is_nasdaq_100 False Zip 6300 Quote Type EQUITY
Industry Biotechnology Long Name MoonLake Immunotherapeutics Regular Market Day Low 52.37
Held Percent Institutions 0.9815 Current Price 54.24 Enterprise To Ebitda -27.08
Financial Currency USD Current Ratio 25.51 Industry Disp Biotechnology
Number Of Analyst Opinions 13 Country Switzerland Float Shares 25 M
Two Hundred Day Average 46.68 Enterprise Value 2 B Forward PE -21.35
Regular Market Volume 76068 Ebitda -108452872 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies.

It develops Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases; and hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, and psoriasis.

MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.